Related Experiment Video
Updated: Jul 3, 2025

13:44
Detection of Architectural Distortion in Prior Mammograms via Analysis of Oriented Patterns
Published on: August 30, 2013
42.9K
Dual view deep learning for enhanced breast cancer screening using mammography
Samuel Rahimeto Kebede1,2, Fraol Gelana Waldamichael3, Taye Girma Debelee3,4
1Research Development Cluster, Ethiopian Artificial Intelligence Institute, Addis Ababa, 40782, Ethiopia. samuel.rahimeto@aii.et.
Scientific Reports
|February 15, 2024
Summary
This study introduces an AI model for breast cancer screening in Ethiopia, improving early detection rates. The model assists radiologists by identifying abnormalities and prioritizing patients, enhancing diagnostic accuracy.
Area of Science:
- Medical Imaging
- Artificial Intelligence in Healthcare
- Oncology
Background:
- Breast cancer is the most common cancer among Ethiopian women, often diagnosed late.
- Mammography screening is effective for early detection but requires expert radiologists, who are scarce in Ethiopia.
Purpose of the Study:
- To develop an AI model to aid radiologists in mass breast cancer screening.
- To improve early detection and patient prioritization for breast abnormalities.
Main Methods:
- An ensemble of EfficientNet-based classifiers was combined with YOLOv5 for suspicious mass detection.
- An abnormality detection model was integrated to enhance screening.
- The model aims to provide explanations for predictions and improve sensitivity.
Main Results:
- The classifier model achieved an F1-score of 0.87 and sensitivity of 0.82.
- Incorporating YOLOv5 suspicious mass detection increased sensitivity to 0.89.
- The F1-score slightly decreased to 0.79 with the addition of mass detection.
Conclusions:
- The developed AI model shows promise in assisting breast cancer screening in resource-limited settings like Ethiopia.
- Combining classification with object detection (YOLOv5) improves sensitivity for detecting abnormalities.
- Further refinement is needed to balance sensitivity and F1-score for optimal clinical utility.

